Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study

BACKGROUND: Most oestrogen receptor (ER)-positive early breast cancer diagnosed today is highly curable with multimodality treatment. Systemic adjuvant treatments including endocrine therapy and chemotherapy have made a significant contribution to the increasing cure rates over the past three decade...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeo, B, Zabaglo, L, Hills, M, Dodson, A, Smith, I, Dowsett, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522631/
https://www.ncbi.nlm.nih.gov/pubmed/26180920
http://dx.doi.org/10.1038/bjc.2015.222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522631/
https://www.ncbi.nlm.nih.gov/pubmed/26180920
http://dx.doi.org/10.1038/bjc.2015.222

Ejemplares similares